Hernia Surgery Urinary Retention
- Registration Number
- NCT03027115
- Lead Sponsor
- Memorial Health University Medical Center
- Brief Summary
Investigating whether pre-operative treatment with a selective alpha1-adrenoceptor antagonist affects the likelihood of male patients developing post-operative urinary retention following hernia repair.
- Detailed Description
The purpose of this study will be to investigate whether pre-operative treatment with a selective alpha1-adrenoceptor antagonist affects the likelihood of male patients developing post-operative urinary retention following hernia repair surgery. It is also of interest to determine whether or not a well-known urological screening tool, the IPSS, can identify patients at risk for urinary retention following elective laparoscopic or open hernia repair surgery. We will investigate if it is possible to pre-treat patients with a selective alpha1-adrenoceptor antagonist which we think can reduce the incidence of post-operative urinary retention and the associated adverse consequences, especially in those patients at higher risk.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Male
- Target Recruitment
- 140
- Male
- 18 years of age
- Presenting with hernia requiring surgical intervention
- Intolerability of tamsulosin or related drugs
- Investigator discretion
- Unwillingness or inability to comply with protocol procedures and assessments
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Treatment Tamsulosin treatment with a selective alpha1-adrenoceptor antagonist
- Primary Outcome Measures
Name Time Method Post-operative urinary retention 2 weeks Incidence of post-operative urinary retention in patients undergoing hernia repair
- Secondary Outcome Measures
Name Time Method Effect of IPSS 2 weeks the variance in the relationship between treatment arm and incidence of post-operative urinary retention in patients undergoing hernia repair that is attributable to International Prostate Symptom Score (IPSS)
Trial Locations
- Locations (1)
Memorial Health University Medical Center
🇺🇸Savannah, Georgia, United States